Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heck, C.
Right arrow Articles by DeGiorgio, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heck, C.
Right arrow Articles by DeGiorgio, C. M.

Neurology 2002;59:S31-S37
© 2002 American Academy of Neurology

Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology.

Vagus nerve stimulation therapy, epilepsy, and device parameters

Scientific basis and recommendations for use

Christi Heck, MD, Sandra L. Helmers, MD and Christopher M. DeGiorgio, MD

From the USC Department of Neurology, Keck School of Medicine, Los Angeles, California (Dr. Heck); Emory University School of Medicine, Atlanta, Georgia (Dr. Helmers); and UCLA Department of Neurology, Los Angeles, California (Dr. DeGiorgio).

Address correspondence and reprint requests to Dr. Christopher M. DeGiorgio, UCLA Department of Neurology, Reed Neurological Research Center, 710 Westwood Plaza, Los Angeles, CA 90024. e-mail: cmd{at}mednet.ucla.edu

Article abstract Our understanding of a precise dose-response relationship for vagus nerve stimulation (VNS) therapy in the treatment of seizures is still evolving. Because several parameters are involved in VNS therapy, the individual contribution of each is not well understood. This review discusses the efficacy of stimulation parameters used in the VNS clinical trials. The background, influence on safety and efficacy, and role in helping to achieve seizure control are discussed for each VNS device parameter: output current, pulse duration, frequency, and duty cycle. Finally, we provide an algorithm for the adjustment of VNS device settings (see Appendices).




This article has been cited by other articles:


Home page
NeurologyHome page
C. DeGiorgio, C. Heck, S. Bunch, J. Britton, P. Green, M. Lancman, J. Murphy, P. Olejniczak, J. Shih, S. Arrambide, et al.
Vagus nerve stimulation for epilepsy: Randomized comparison of three stimulation paradigms
Neurology, July 26, 2005; 65(2): 317 - 319.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
A. R. C. Kelso and H. R. Cock
Advances in epilepsy
Br. Med. Bull., April 21, 2005; 72(1): 135 - 148.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.